Newsletter | November 18, 2026

11.18.26 -- What Will It Take To Turn CGT Innovation Into Market Success?

FOCUS ON REGULATORY & COMPLIANCE

What Will It Take To Turn CGT Innovation Into Market Success?

This session recap from Advanced Therapies USA Congress 2026 explains why the CGT industry cannot evaluate success through clinical data alone.

Operationalizing Global Oncology Trials: Fast-Track Development Timelines

Running oncology trials across multiple regions? Learn how coordinated planning, oversight, and expertise keep complex studies on track from start to registration.

An Overview Of 2026 Life Sciences Industry Trends

Explore the paradigm shift reshaping life sciences, how connected data streams across the product lifecycle drive predictive compliance and operational excellence.

Why CGT Commercialization Demands Early Regulatory And Market Planning

Commercialization decisions in cell and gene therapy are made earlier than most manufacturers expect, with regulatory, manufacturing, and market access implications that compound over time.

Audit Ready From Day 1: A Cleaning & Disinfection Readiness Guide

Build audit readiness into your facility design from day one. See how early cross-functional engagement and early contamination control planning prevent costly startup delays and rework.

The Automation Advantage: Reducing Risk In Cell Therapy Production

Automated bioprocessing platforms transform complex cell therapy workflows into scalable, fully compliant manufacturing pathways to lower costs and expand access.

What FDA CRLs Reveal About Cell-Based Potency Assays

Cell-based potency assay deficiencies contribute to regulatory concerns. Read about the issues driving these CRLs and consider how to build a stronger cell-based potency assay strategy.

The Secret To Digital Transformation? Strategic Orchestration And AI Governance

By collecting, harmonizing, and contextualizing data to support predictive insights and real-time monitoring, manufacturers can improve operational responsiveness and make more informed decisions.

Optimizing Bioprocess Design And Workflow Orchestration

Disconnected systems can slow development by making data harder to coordinate. Discover how workflow orchestration and structured experimental design can help labs reduce friction and improve efficiency.

Expand Trial Footprints Without Expanding Cryopreservation Risk

Transitioning from fresh to frozen starting material stabilizes cell therapy inputs, but isolated workflows introduce risk. Integrated logistics safeguard quality as trial footprints expand.

What Makes A RABS Design Effective In Aseptic Manufacturing?

Choosing among passive open, active open, and closed barrier configurations is only the first step. Airflow, equipment geometry, and intervention frequency determine whether a design protects the process.

Annex 1 In Practice: Turning CCS Into Cleanroom Design

Grasp how embedding a contamination control strategy into early facility design mitigates risk, protects product quality, and ensures regulatory compliance.

General Wellness Isn't A Vibe Anymore: What The 2026 FDA Update Means

The FDA’s 2026 guidance has put an end to "wellness by disclaimer." Learn how new standards for wearables and apps impact study design, participant safety, and the evolving ethical role of the IRB.

How Phase I Trial Ethics Are Changing For Sponsors

As early efficacy becomes possible in Phase I studies, hope for benefit must be weighed against limited knowledge, reshaping consent language, risk-benefit review, and protocol design for sponsors and IRBs.

Advancing The Human Liver-Chip Toward FDA Qualification

Investigate how human-relevant liver models can improve DILI risk assessment and support stronger development decisions while advancing toward regulatory qualification and scaling into automated studies.

REGULATORY & COMPLIANCE SOLUTIONS

•

Clean With Ease With These Sporicidal Wipes - Contec, Inc.

•

Full Service CRO And Regulatory Partner For Biologics - Veristat, Inc.

•

Dynamic Pass Boxes And Dynamic Floor Laminar Hatches - Esco Lifesciences

•

One Partner For Your Entire Drug Development Journey - Solvias

•

Material Transfer Isolator System - TEMA SINERGIE

Connect With Cell & Gene: